EN
HI
Summary
As of 4 Sep, 2026, Senores Pharmaceuticals stock price is ₹1430.4. During the trading session, the stock has moved between an intraday low of ₹1424.00 and an intraday high of ₹1462.40. Over the last 52 weeks, Senores Pharmaceuticals has traded between ₹662.45 and ₹1599.00.
The stock has recorded a trading volume of 1,11,671 shares, with a market capitalization of ₹46053588. Its Average Traded Price (ATP) is ₹1437.11, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹1430.40.
Senores Pharmaceuticals has an upper circuit limit of ₹1739.40 and a lower circuit limit of ₹1159.60. The total value traded stands at ₹16.05 CR, and the delivery percentage for the day is 46.29%.
The stock is currently traded with a market lot size of 1. Senores Pharmaceuticals also offers a dividend yield of 0%.
Senores Pharmaceuticals share price chart
Senores Pharmaceuticals Share Key Metrics
Volume
1.12 L
Market Cap
6587.51 CR
LTQ@LTP
25@1430.40
ATP
1437.11
Var Margin
20.34 %
Circuit Range
1159.6-1739.4
Delivery %
46.29 %
Value
16.05 CR
ASM/GSM
No
Market Lot
1
Senores Pharmaceuticals Fundamentals
P/E Ratio
52.85
P/B Ratio
6.93
Div. Yield
0
Sector P/E
41.68
Sector P/B
3.55
Sec. Div. Yield
0.5
Senores Pharmaceuticals Resistance and Support
Pivot 1456.17
Resistance
First Resistance
1472.14
Second Resistance
1494.77
Third Resistance
1510.74
Support
First Support
1433.54
Second Support
1417.57
Third Support
1394.94
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 03 2026 | 1450 | 1430.4 | -1.32% | 1462.4 | 1424 |
| Wed Sep 02 2026 | 1454.69 | 1449.5 | -0.36% | 1478.8 | 1440.19 |
| Tue Sep 01 2026 | 1442.3 | 1454.69 | 1.53% | 1469.9 | 1424.3 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Senores Pharmaceuticals will attend an Investor Conference hosted by Elara Capital on September 2, 2026. The meeting will involve both group and one-on-one interactions in Mumbai, discussing publicly available information.
Aug 27 2026 12:45:07
Senores Pharmaceuticals Ltd - 544319 - Board Meeting Outcome for Senores Pharmaceuticals Limited Has Informed The Exchange Regarding Outcome Of Board Meeting
Senores Pharmaceuticals' Board approved the incorporation of a Wholly-Owned Subsidiary in Mexico and a Subsidiary Company in Canada. This move aims to support the company's business and strategic objectives in these international markets.
Aug 26 2026 18:54:21
Read More
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Aarti Pharmalabs Ltd.
868.10
0.85 (0.10%)
Sanofi India Ltd.
3190.80
33.40 (1.06%)
Symbiotec Pharmalab Ltd.
1076.85
-15.95 (1.46%)
Nephrocare Health Services Ltd.
706.75
14.05 (2.03%)
Bliss GVS Pharma Ltd.
639.35
-9.30 (1.43%)
Kovai Medical Center & Hospital Ltd.
6091.50
74.00 (1.23%)
Innova Captab Ltd.
1125.40
16.80 (1.52%)
Morepen Laboratories Ltd.
117.45
5.48 (4.89%)
Orchid Pharma Ltd.
934.65
-3.40 (0.36%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1430.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 52.85. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 6.93. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.68 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 6587.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1599.00 & 662.45. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
